Regeneron Pharmaceuticals Inc.

In News

Regeneron Pharmaceuticals (REGN) Wins FDA Approval For Pasatru In Adult FOP - Yahoo Finance

Yahoo Finance - Aug 29, 2026

Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

MarketWatch - Aug 28, 2026

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire

GlobeNewswire - Aug 27, 2026

Regeneron Pharmaceuticals Inc. Buys New Stake in Parabilis Medicines, Inc. $PBLS - MarketBeat

MarketBeat - Aug 29, 2026

Regeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - PR Newswire

PR Newswire - Aug 26, 2026

Robbins LLP Reminds REGN Stockholders of the Pending Lead Plaintiff Deadline in the Class Action Against Regeneron Pharmaceuticals, Inc. - TMX Newsfile

TMX Newsfile - Aug 26, 2026

Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com

Barchart.com - Aug 26, 2026

Regeneron Pharmaceuticals (REGN) As Pasatru Approval Tests An Undervalued View - Yahoo Finance

Yahoo Finance - Aug 30, 2026

REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky - PR Newswire

PR Newswire - Aug 26, 2026

Bronstein, Gewirtz & Grossman LLC Urges Regeneron - GlobeNewswire

GlobeNewswire - Aug 26, 2026

Regeneron Pharmaceuticals (REGN) Adjusts Course Amid Mixed Results in Melanoma Drug Trials - Yahoo Finance

Yahoo Finance - Aug 27, 2026

REGN DEADLINE: SueWallSt Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire

PR Newswire - Aug 27, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment